Back

Human GPR174 deficiency drives polyclonal lymphoproliferative disease via defects in T cell function

Huang, Y.-H.; Arana, K.; Rachimi, S.; Tam, H.; Spegarova, J. S.; Engelhardt, K. R.; Griffin, H.; Mee, M.; Miano, M.; Raggi, F.; Grossi, A.; Rusmini, M.; Ceccherini, I.; Dell'Orso, G.; Ferro, J.; Giarratana, M. C.; Pillai, V.; Banka, S.; Garcez, T.; Briggs, T. A.; Mellouli, F.; von Hardenberg, S.; Beier, R.; Auber, B.; Baumann, U.; Tawamie, H.; Behrens, E.; Oldridge, D. A.; Cabrera, E. C.; Xu, Y.; Ouyang, S.; Hambleton, S.; Romberg, N.; Cyster, J. G.

2026-07-17 rheumatology
10.64898/2026.07.14.26357774 medRxiv
Show abstract

The X-linked G-protein coupled receptor GPR174 is highly expressed in T and B lymphocytes and has immunoregulatory roles in mice, but its function in humans is unknown. We describe a cohort of six individuals who have function-disrupting variants in GPR174 and a clinical phenotype of lymphadenopathy and autoimmunity. Histological analysis of two patient lymph nodes revealed necrotizing lymphadenitis and lymphoproliferation resembling Kikuchi-Fujimoto disease. In-depth analysis of three patients and related carriers revealed overaccumulation of CD8 terminally differentiated effector memory cells re-expressing CD45RA (TEMRA). Patient cells and GPR174-deficient CD8 T cells generated from controls showed less repression of proliferation by the GPR174 ligand lysophosphatidylserine (lysoPS) and an effector-biased gene expression program. GPR174-deficient CD4 T cells were resistant to lysoPS-mediated suppression of IL2 production. In mice, chronic viral infection led to over-accumulation of GPR174-deficient effector CD8 T cells. We describe an inborn error of immunity associated with dysregulated lymphocyte responses that we propose predisposes to exaggerated lymphoproliferation and autoimmunity following viral infection.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
JCI Insight
277 papers in training set
Top 0.1%
19.0%
2
Nature Communications
5641 papers in training set
Top 15%
12.2%
3
Genome Medicine
183 papers in training set
Top 0.2%
8.1%
4
eBioMedicine
183 papers in training set
Top 0.5%
4.4%
5
Cell Reports Medicine
153 papers in training set
Top 0.5%
4.4%
6
Journal of Allergy and Clinical Immunology
27 papers in training set
Top 0.1%
3.5%
50% of probability mass above
7
Science Immunology
88 papers in training set
Top 0.7%
3.5%
8
The Lancet Rheumatology
11 papers in training set
Top 0.1%
3.3%
9
Frontiers in Immunology
638 papers in training set
Top 4%
3.3%
10
Nature
645 papers in training set
Top 5%
2.7%
11
Rheumatology
24 papers in training set
Top 0.2%
2.5%
12
Viruses
332 papers in training set
Top 2%
2.5%
13
The Journal of Infectious Diseases
202 papers in training set
Top 1%
2.5%
14
Journal of Experimental Medicine
119 papers in training set
Top 1%
2.2%
15
Cell
431 papers in training set
Top 6%
1.8%
16
The Journal of Immunology
166 papers in training set
Top 1%
1.7%
17
Annals of the Rheumatic Diseases
36 papers in training set
Top 0.3%
1.5%
18
Journal of Clinical Investigation
179 papers in training set
Top 3%
1.5%
19
PLOS Pathogens
820 papers in training set
Top 7%
1.4%
20
Arteriosclerosis, Thrombosis, and Vascular Biology
71 papers in training set
Top 0.9%
1.2%
21
Human Genetics and Genomics Advances
84 papers in training set
Top 1%
1.2%
22
Nature Immunology
79 papers in training set
Top 2%
1.2%
23
Journal of Clinical Immunology
14 papers in training set
Top 0.2%
0.9%
24
Genome Biology
637 papers in training set
Top 9%
0.6%
25
Science Translational Medicine
127 papers in training set
Top 4%
0.6%
26
Cell Reports
1498 papers in training set
Top 28%
0.6%
27
Immunity
67 papers in training set
Top 2%
0.6%